For filings with the FSA include the
annex
For filings with issuer exclude the
annex
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
1. Identity of the issuer or the underlying PENDRAGON PLC
issuer
of existing shares to which voting rights
are
attached: ii
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights YES
An acquisition or disposal of qualifying financial instruments which n/a
may
result in the acquisition of shares already issued to which voting
rights
are attached
An acquisition or disposal of instruments with similar economic effect n/a
to
qualifying financial instruments
An event changing the breakdown of voting rights n/a
Other (please n/a
specify):
3. Full name of person(s) subject to UBS Investment Bank
the
notification obligation: iii
4. Full name of shareholder(s) UBS AG London Branch
(if different from 3.):iv
5. Date of the transaction and date 9 November 2009
on
which the threshold is crossed or
reached: v
6. Date on which issuer notified: 11 November 2009
7. Threshold(s) that is/are crossed 6%
or
reached: vi, vii
8. Notified details:
A: Voting rights attached to shares viii, ix
35,885,08335,885,083
Class/type of Situation previous Resulting situation after
shares to the triggering the triggering
transaction transaction
if possible Number Number Number Number of % of voting
using of of of shares voting rights x
the ISIN CODE Shares Voting rights
Rights
Direct Direct xi Indirect Direct Indirect
xii
Ordinary Share 39,946,609 39,946,609 6.03%
(GB00B1JQBT10)
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date xiii Conversion Period rights that may be rights
xiv acquired if the
instrument is
exercised/
converted.
C: Financial Instruments with similar economic effect to Qualifying Financial
Instruments xv, xvi
Resulting situation after the triggering transaction
Type of Exercise Expiration Exercise/ Number of voting % of voting
financial price date xvii Conversion rights instrument rights xix, xx
instrument period refers to
xviii
Nominal Delta
Total (A+B+C)
Number of voting rights Percentage of voting rights
Orindary Shares 6.03%
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable: xxi
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy
holder will cease
to hold:
12. Date on which proxy holder will
cease to hold
voting rights:
13. Additional information:
14. Contact name: Richard Maloney
15. Contact telephone number: 01623 725200
Note: Annex should only be submitted to the FSA not the issuer
Annex: Notification of major interests in sharesxxii
A: Identity of the persons or legal entity subject to the notification
obligation
Full name
(including legal form of legal
entities)
Contact address
(registered office for legal entities)
Phone number & email
Other useful information
(at least legal representative for
legal persons)
B: Identity of the notifier, if applicable
Full name
Contact address
Phone number & email
Other useful information(e.g.
functional relationship
with the person or legal entity subject
to the notification
obligation)
C: Additional information
For notes on how to complete form TR-1 please see the FSA website.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.